(Q53826888)

English

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 May 2018

http://europepmc.org/abstract/MED/29508247

Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eileen M. O'Reilly

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

author name string

Herbert Hurwitz

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Eric Van Cutsem

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Johanna Bendell

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Manuel Hidalgo

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Chung-Pin Li

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Marcelo Garrido Salvo

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Teresa Macarulla

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Vaibhav Sahai

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Ashwin Sama

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Edward Greeno

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Kenneth H Yu

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Chris Verslype

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Fitzroy Dawkins

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Chris Walker

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Jason Clark

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

publication date

6 March 2018

1 reference

Europe PubMed Central

PubMed publication ID

20 May 2018

http://europepmc.org/abstract/MED/29508247

Investigational New Drugs

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

36

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

683-695

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ruxolitinib for the treatment of myelofibrosis: its clinical potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology and clinical management of myeloproliferative neoplasms and development of the JAK inhibitor ruxolitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarifying the use of ruxolitinib in patients with myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer cachexia: a review of mechanisms and therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Host systemic inflammatory response influences outcome in pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Statistics, 2017.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29508247

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-018-0580-2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6752723&resulttype=core&format=json

12 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53826888&oldid=2212302688"